SPREMA
DEAD

Serial Number

78316832

Owner

Churchill, John, N.

First Use Date

Aug 2, 2003

Filing Date

Oct 22, 2003

Add to watchlist:

No watchlists yet
View on USPTO

SPREMA Trademark

Serial Number: 78316832

SPREMA is a trademark filed by Churchill, John, N. on October 22, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Churchill, John, N.

20 Chiltern Hills Road
Beaconsfield HP9 1PL , GB

Entity Type: 01

Trademark Details

Filing Date

October 22, 2003

Registration Date

Not Registered

First Use Anywhere

August 2, 2003

First Use in Commerce

August 2, 2003

Goods & Services

In your office action, you stated: 'And with pharmaceutical preparations and similar substances, the applicant must specify, the disease, condition or ailment that the goods are used to treat; TMEP ยงยง1402;01 and 1402;03(a); In addition, the applicant must specify what "gemmotherapeutic" means; As a suggestion therefore, the applicant may adopt the following identification, if accurate: Pharmaceutical and veterinary preparations, namely, herbal and homeopathic preparations and substances used to treat applicant must specify the condition or disease to be treated, e;g;, cancer, indigestion, diabetes, in International Class 005'; The suggested identification is certainly accurate and could be used as such; However, to be more precise, gemmotherapy is a branch of herbal medicine that uses remedies made from the buds and young shoots of trees and shrubs, macerated in alcohol and glycerin and prepared in the 1DH homeopathic potency; This is what the word 'gemmotherapeutic' derives from - it is the adjective from the term 'gemmotherapy'; Gemmotherapy is widely used in parts of Europe but at present is little known in the USA - a search on the website will however reveal several sites that sell these products in America, as well as further information about the therapy itself; If possible, I would therefore like to include the term 'gemmotherapeutic' in the listing of goods; However, if it causes too many problems, it should be left out; Abies pectinata: osteoporosis, growing problems Acer campestris: gallstones, high blood pressure Actinidia chinensis: rheumatoid arthritis Aesculus hippocastanum: haemorrhoids Ailanthus altissima, buds: ulceration, sinusitis Ailanthus altissima, bark of young roots: dysentery Alnus glutinosa: strokes Alnus incana: fibrocystic breasts Ampelopsis veitchii: rheumatoid arthritis Berberis vulgaris: detoxification of liver and gallbladder Betula pubescens, bark of young roots: diuretic Betula pubescens, buds: detoxification of liver, gout Betula pubescens, catkins: low libido Betula pubescens, rootlets: raised cholesterol, diuretic Betula verrucosa, buds: rheumatism, fibrocystic breasts Betula verrucosa, sap: gout, kidney stones Betula verrucosa, seeds: memory loss Buddleja davidii: visual disturbances Calluna vulgaris: urinary tract infections Carpinus betulus: sinusitis Castanea vesca: haemorrhoids Cedrus libani: dry skin Cercis siliquastrum: thrombosis Citrus limonum, bark: angina Citrus limonum, buds: hyperacidity Cornus sanguinea: thrombosis Coryllus avellana: emphysema Crataegus oxycantha: angina Fagus sylvatica: water retention Ficus carica, buds: hyperacidity Ficus carica, rootlets: constipation Filipendula ulmaria: arthritis Fraxinus excelsior: glaucoma Fraxinus ornus: impotence Ginkgo biloba: strokes Hedera helix: obesity Hippophae rhamnoides: low resistance Ilex aquifolium: kidney deficiency Juglans regia: eczema Juniperus communis: liver problems Laurus nobilis: disorders of the gonads Ligustrum vulgare: bronchitis Lonicera nigra: hepatitis Magnolia denudata: upper respiratory tract infections Morus nigra: diabetes Olea europaea: hypertension Ostrya carpinifolia: sinusitis Pinus montana: osteoarthritis, rheumatism Pinus sylvestris: arthrosis Platanus orientalis: acne Populus nigra: thrombophlebitis Prunus amygdalus: hypertension Quercus pedunculata, buds: physical debility Quercus pedunculata, acorns: sexual debility Quercus pedunculata, catkins: loss of libido Quercus pedunculata, rootlets: bedsores, eczema Ribes nigrum: adrenal insufficiency Rosa canina: inflammations Rosmarinus officinalis: cirrhosis of the liver Rubus fruticosus: problems of the gonads Rubus idaeus: inflammation of the ovaries Salix alba, bark: arthritis Salix alba, buds: insomnia Salix alba, catkins: amenorrhoea Sanguisorba officinalis: diarrhoea Secale cereale: hepatitis Sequoia giganteum: prostatitis Silybum marianum: liver problems Sorbus domestica: venous insufficiency Sorbus torminalis: menopausal problems Syringa vulgaris: angina Tamarix gallica: problems of the spleen Thymus vulgaris: high cholesterol Tilia tomentosa: anxiety, insomnia Ulmus campestris: eczema, acne Vaccinium myrtillus: fragile capillaries Vaccinium vitis idaea: diarrhoea Viburnum lantana: asthma Vitis vinifera: arthritis Zea mays: heart attack Zizyphus jujuba, buds: insomnia, anxiety Zizyphus jujuba, seeds: memory and concentration loss

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 20, 2006 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 17, 2006 ABN2
FINAL REFUSAL E-MAILED
Aug 19, 2005 GNFR
FINAL REFUSAL WRITTEN
Aug 19, 2005 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2005 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2005 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2005 TROA
NON-FINAL ACTION E-MAILED
Mar 14, 2005 GNRT
NON-FINAL ACTION WRITTEN
Mar 14, 2005 CNRT
AMENDMENT FROM APPLICANT ENTERED
Feb 25, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2005 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2005 TROA
PETITION TO REVIVE-GRANTED
Feb 9, 2005 PETG
TEAS PETITION TO REVIVE RECEIVED
Feb 9, 2005 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 9, 2004 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 9, 2004 ABN2
EMAIL RECEIVED
May 17, 2004 EMRV
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
May 13, 2004 UNPR
NON-FINAL ACTION E-MAILED
May 12, 2004 GNRT
ASSIGNED TO EXAMINER
May 12, 2004 DOCK
NEW APPLICATION ENTERED
Nov 5, 2003 NWAP